Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/2092
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUral, Ali Uğur-
dc.contributor.authorAvcu, Ferit-
dc.contributor.authorBaran, Yusuf-
dc.date.accessioned2016-08-12T08:35:54Z-
dc.date.available2016-08-12T08:35:54Z-
dc.date.issued2007-07-
dc.identifier.citationUral, A. U., Avcu, F., and Baran, Y. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 110(2), 469-470. doi:10.1002/cncr.22804en_US
dc.identifier.issn0008-543X-
dc.identifier.urihttp://doi.org/10.1002/cncr.22804-
dc.identifier.urihttp://hdl.handle.net/11147/2092-
dc.descriptionCorrespondenceen_US
dc.description.abstractWe read the interesting article by Jagsi et al on the increased rates of coronary artery disease in patients treated with radiation therapy for early-stage breast cancer.1 In their study, those authors concluded that the findings support further assessment of clinical outcomes when newer techniques of chemotherapy planning are employed as well as investigation of the potential role of innovative techniques. However, there was no mention of the novel radiosensitizing and chemosensitizing effects of bisphosphonates (BPs), which inhibit tumor cell adhesion to bone, and tumor growth in breast cancer.en_US
dc.language.isoenen_US
dc.publisherJohn Wiley and Sons Inc.en_US
dc.relation.ispartofCanceren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBisphosphonic acid derivativeen_US
dc.subjectRadiosensitizing agenten_US
dc.subjectZoledronic aciden_US
dc.subjectBreast canceren_US
dc.subjectCancer inhibitionen_US
dc.titleRates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast canceren_US
dc.typeLetteren_US
dc.authorid0000-0002-1056-4673en_US
dc.institutionauthorBaran, Yusuf-
dc.departmentİzmir Institute of Technology. Molecular Biology and Geneticsen_US
dc.identifier.volume110en_US
dc.identifier.issue2en_US
dc.identifier.startpage469en_US
dc.identifier.endpage470en_US
dc.identifier.wosWOS:000247985600032en_US
dc.identifier.scopus2-s2.0-34547148070en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.1002/cncr.22804-
dc.identifier.pmid17559123en_US
dc.relation.doi10.1002/cncr.22804en_US
dc.coverage.doi10.1002/cncr.22804en_US
dc.identifier.wosqualityQ1-
dc.identifier.scopusqualityQ1-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeLetter-
item.languageiso639-1en-
item.fulltextWith Fulltext-
crisitem.author.dept04.03. Department of Molecular Biology and Genetics-
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File Description SizeFormat 
2092.pdfMektup35.3 kBAdobe PDFThumbnail
View/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Apr 5, 2024

WEB OF SCIENCETM
Citations

2
checked on Mar 30, 2024

Page view(s)

326
checked on Apr 22, 2024

Download(s)

184
checked on Apr 22, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.